ACAYDINS Trademark

Trademark Overview

On Wednesday, March 29, 2023, a trademark application was filed for ACAYDINS with the United States Patent and Trademark Office. The USPTO has given the ACAYDINS trademark a serial number of 97863448. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Monday, September 23, 2024. This trademark is owned by InCarda Therapeutics, Inc.. The ACAYDINS trademark is filed in the Pharmaceutical Products category with the following description:

Inhaled pharmaceutical preparations for the treatment of cardiovascular disorders
acaydins

General Information

Serial Number97863448
Word MarkACAYDINS
Filing DateWednesday, March 29, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateMonday, September 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 30, 2024

Trademark Statements

Goods and ServicesInhaled pharmaceutical preparations for the treatment of cardiovascular disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 21, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameInCarda Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNewark, CA 94560
Party NameInCarda Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewark, CA 94560

Trademark Events

Event DateEvent Description
Saturday, April 1, 2023NEW APPLICATION ENTERED
Friday, April 21, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 22, 2023ASSIGNED TO EXAMINER
Friday, December 22, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 10, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 30, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 30, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 26, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, August 29, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, August 29, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 29, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 17, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 17, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 17, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, September 17, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 17, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 17, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, September 23, 2024SOU TEAS EXTENSION RECEIVED
Monday, September 23, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 23, 2024SOU EXTENSION 1 GRANTED
Monday, September 23, 2024SOU EXTENSION 1 FILED

Related Keywords

acaydins cardiovascular disorders treatment preparations pharmaceutical inhaled